ArticleAnnals of surgical oncology2025

ASO Author Reflections: Is There an Extra Benefit of Adding Neoadjuvant Radiotherapy to Chemotherapy in Patients with (Borderline) Resectable Pancreatic Cancer?

Won-Gun Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.